Evidence map›Paper›PMID 15133113›Full record

ArticleMicrobiology (Reading, England)2004

Genome structure in the vole bacillus, Mycobacterium microti, a member of the Mycobacterium tuberculosis complex with a low virulence for humans.

Cristiane C Frota, Debbie M Hunt, Roger S Buxton, Lisa Rickman, Jason Hinds, Kristin Kremer, Dick van Soolingen, M Joseph Colston

Open access · greenAbstract read
In one paragraph

Article in Microbiology (Reading, England), 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 53 citations in OpenAlex.

  1. Rv1899c, an HDAC1-ZBTB25-Interacting Protein ofInternational journal of molecular sciences · 2025
    Article
  2. Genomic comparison betweenFrontiers in veterinary science · 2024
    Article
  3. Ocular mycobacterial lesions in cats.Veterinary pathology · 2022
    Article
  4. Molecular detection ofNew microbes and new infections · 2021
    Article
  5. Microorganisms · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Genome-wide transcription analyses in Mycobacterium tuberculosis treated with lupulone.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2014
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Cristiane C FrotaDivision of Mycobacterial Research, National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK.
Debbie M HuntDivision of Mycobacterial Research, National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK.
Roger S BuxtonDivision of Mycobacterial Research, National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK.
Lisa RickmanDivision of Mycobacterial Research, National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK.
Jason HindsDepartment of Medical Microbiology, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK.
Kristin KremerNational Mycobacteria Reference Laboratory, National Institute of Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands.
Dick van SoolingenNational Mycobacteria Reference Laboratory, National Institute of Public Health and the Environment (RIVM), 3720 BA Bilthoven, The Netherlands.
M Joseph ColstonDivision of Mycobacterial Research, National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK.
National Institute for Public Health and the Environment · NLSt George's Hospital · GB

Funding

Medical Research Council MC_U117585867Medical Research Council U.1175.02.002.00013 (85867)Wellcome Trust 062511
6 · The paper itself

Abstract

Mycobacterium microti, a member of the Mycobacterium tuberculosis complex, is phylogenetically closely related to M. tuberculosis, differing in a few biochemical properties. However, these species have different levels of virulence in different hosts; most notably M. microti shows lower virulence for humans than M. tuberculosis. This report presents genomic comparisons using DNA microarray analysis for an extensive study of the diversity of M. microti strains. Compared to M. tuberculosis H37Rv, 13 deletions were identified in 12 strains of M. microti, including the regions RD1 to RD10, which are also missing in Mycobacterium bovis BCG. In addition, four new deleted regions, named MiD1, RD1beta, MiD2 and MiD3, were identified. DNA sequencing was used to define the extent of most of the deletions in one strain. Although RD1 of M. bovis BCG and M. microti is thought to be crucial for attenuation, in this study, three of the four M. microti strains that were isolated from immunocompetent patients had the RD1 deletion. In fact, only the RD3 deletion was present in all of the strains examined, although deletions RD7, RD8 and MiD1 were found in almost all the M. microti strains. These deletions might therefore have some relation to the different host range of M. microti. It was also noticeable that of the 12 strains studied, only three were identical; these strains were all isolated from immunocompetent humans, suggesting that they could have arisen from a single source. Thus, this study shows that it is difficult to ascribe virulence to any particular pattern of deletion in M. microti.

Indexed as

Genetic VariationGenome, BacterialOligonucleotide Array Sequence AnalysisAnimalsArvicolinaeBacterial ProteinsGene DeletionGenomicsHumansMycobacteriumMycobacterium tuberculosisTuberculosisVirulenceBacterial Proteins

Identifiers

PMID15133113
PMCPMC2964484
OpenAlexW1975627464

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.